SB1042 • 2026

RELATING TO MENTAL HEALTH.

Budget

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor: LEE, C., CHANG
Last action: 2026-04-02
Official status: Received notice of the discharge of all House Conferees (Hse. Com. No. 457).
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

RELATING TO MENTAL HEALTH.

What This Bill Does

RELATING TO MENTAL HEALTH.
Mental Health Emerging Therapies Pilot Program; Office of Wellness and Resilience; Appropriation ($) Establishes a two-year Mental Health Emerging Therapies Pilot Program within the Office of Wellness and Resilience.
Appropriates funds.
Effective 7/1/3000.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

HD1

Hawaii published version HD1

Plain English: SB1042 HD1 THE SENATE S.B.

SB1042 HD1 THE SENATE S.B.
NO.
1042 THIRTY-THIRD LEGISLATURE, 2025 S.D.
1 STATE OF HAWAII H.D.

SD1

Hawaii published version SD1

Plain English: SB1042 SD1 THE SENATE S.B.

SB1042 SD1 THE SENATE S.B.
NO.
1042 THIRTY-THIRD LEGISLATURE, 2025 S.D.
1 STATE OF HAWAII A BILL FOR AN ACT RELATING TO MENTAL HEALTH .

Bill History

2026-04-02 S
Received notice of the discharge of all House Conferees (Hse. Com. No. 457).
2026-04-01 H
House Conferee(s) discharged.
2026-03-20 H
Received notice of all Senate conferees being discharged (Sen. Com. No. 409).
2026-03-20 S
Senate Conferee(s) discharged.
2025-12-08 D
Carried over to 2026 Regular Session.
2025-04-25 S
Conference committee meeting to reconvene on 04-25-25 5:20 PM; Conference Room 329.
2025-04-24 S
Conference committee meeting scheduled for 04-25-25 3:15PM; Conference Room 329.
2025-04-21 H
Received notice of Senate conferees (Sen. Com. No. 848).
2025-04-21 S
Senate Conferees Appointed: San Buenaventura Chair; Lee, C. Co-Chair; Hashimoto, Fevella.
2025-04-21 S
Received notice of appointment of House conferees (Hse. Com. No. 754).
2025-04-17 H
House Conferees Appointed: Takayama, Takenouchi Co-Chairs; Alcos.
2025-04-10 H
Received notice of disagreement (Sen. Com. No. 779).
2025-04-10 S
Senate disagrees with House amendments.
2025-04-10 S
Received from House (Hse. Com. No. 668).
2025-04-08 H
Passed Third Reading with none voting aye with reservations; Representative(s) Kila, Kitagawa, Lamosao, Matayoshi, Pierick voting no (5) and Representative(s) Cochran, Marten excused (2). Transmitted to Senate.
2025-04-04 H
Reported from FIN (Stand. Com. Rep. No. 2011), recommending passage on Third Reading.
2025-04-02 H
The committee on FIN recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 15 Ayes: Representative(s) Yamashita, Takenouchi, Grandinetti, Holt, Hussey, Keohokapu-Lee Loy, Kitagawa, Kusch, Lamosao, Lee, M., Miyake, Morikawa, Templo, Alcos, Reyes Oda; Ayes with reservations: none; Noes: none; and Excused: none.
2025-03-31 H
Bill scheduled to be heard by FIN on Wednesday, 04-02-25 3:30PM in House conference room 308 VIA VIDEOCONFERENCE.
2025-03-18 H
Passed Second Reading as amended in HD 1 and referred to the committee(s) on FIN with none voting aye with reservations; Representative(s) Pierick voting no (1) and Representative(s) Cochran, Ward excused (2).
2025-03-18 H
Reported from HLT (Stand. Com. Rep. No. 1312) as amended in HD 1, recommending passage on Second Reading and referral to FIN.
2025-03-14 H
The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Chun, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; 0 Noes: none; and 0 Excused: none.
2025-03-11 H
Bill scheduled to be heard by HLT on Friday, 03-14-25 9:00AM in House conference room 329 VIA VIDEOCONFERENCE.
2025-03-04 H
Referred to HLT, FIN, referral sheet 18
2025-03-04 H
Pass First Reading
2025-02-28 H
Received from Senate (Sen. Com. No. 50) in amended form (SD 1).
2025-02-28 S
Report Adopted; Passed Third Reading. Ayes, 22; Aye(s) with reservations: Senator(s) McKelvey. Noes, 1 (Senator(s) Awa). Excused, 2 (Senator(s) Fukunaga, Kidani). Transmitted to House.
2025-02-27 S
One Day Notice 02-28-25.
2025-02-27 S
Reported from WAM (Stand. Com. Rep. No. 782) with recommendation of passage on Third Reading.
2025-02-19 S
The committee(s) on WAM recommend(s) that the measure be PASSED, UNAMENDED. The votes in WAM were as follows: 13 Aye(s): Senator(s) Dela Cruz, Moriwaki, Aquino, DeCoite, Elefante, Hashimoto, Inouye, Kanuha, Kidani, Kim, Lee, C., Wakai, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
2025-02-14 S
The committee(s) on WAM will hold a public decision making on 02-19-25 10:02AM; Conference Room 211 & Videoconference.
2025-02-14 S
Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.
2025-02-14 S
Reported from HHS (Stand. Com. Rep. No. 625) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.
2025-02-12 S
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
2025-02-07 S
The committee(s) on HHS has scheduled a public hearing on 02-12-25 1:00PM; Conference Room 225 & Videoconference.
2025-01-23 S
Referred to HHS, WAM.
2025-01-21 S
Passed First Reading.
2025-01-17 S
Introduced.

Official Summary Text

RELATING TO MENTAL HEALTH.
Mental Health Emerging Therapies Pilot Program; Office of Wellness and Resilience; Appropriation ($)
Establishes a two-year Mental Health Emerging Therapies Pilot Program within the Office of Wellness and Resilience. Appropriates funds. Effective 7/1/3000. (HD1)

Current Bill Text

Read the full stored bill text

SB1042

THE SENATE

S.B. NO.

1042

THIRTY-THIRD LEGISLATURE, 2025

STATE OF HAWAII

A BILL FOR AN ACT

relating
to mental health
.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

����
SECTION 1.
�
Chapter 321, Hawaii Revised Statutes, is
amended by adding a new section to part I to be appropriately designated and to
read as follows:

����
"
�321-
��

��
Mental health emerging
therapies special fund.
�
(a)
�

There is established in the state treasury the mental health emerging
therapies special fund to be administered by the department of health.
�
The following moneys shall be deposited into
the fund:

����
(1)
�
Appropriations by the legislature to
the special fund; and

����
(2)
�
Gifts, donations, and grants from
public agencies and private persons.

All
interest earned or accrued on moneys deposited into the special fund shall
become part of the special fund.

����
(b)
�
Moneys in the special fund shall be expended
to support clinical research and the development of emerging therapies for the
treatment of mental health and behavioral health disorders.
�
Among other purposes, the moneys may be used
for:

����
(1)
�
Establishing public-private
partnerships to jointly fund phase three clinical trials of United States Food
and Drug Administration breakthrough therapies;

����
(2)
�
Funding investor-initiated clinical
trials, including trials to:

���������
(A)
�
Inform optimal methods of treatment
delivery; and

���������
(B)
�
Inform transdiagnostic safety and efficacy;

����
(3)
�
Establishing compassionate use
programs, including data collection and analysis;

����
(4)
�
Funding education and training
opportunities for mental health professionals;

����
(5)
�
Supporting public education and harm
reduction;

����
(6)
�
Developing patient access pilot
programs, including real-world data collection and analysis;

����
(7)
�
Establishing community programs to
provide long-term patient support services; and

����
(8)
�
Funding implementation studies,
including research and analyses of best practices, cost effectiveness, and
methods to reduce treatment costs.

����
(c)
�
The department shall adopt rules pursuant to
chapter 91 for the administration of the mental health emerging therapies
special fund.

����
(d)
�
The department shall submit to the
legislature no later than twenty days prior to the convening of each regular
session, beginning with the regular session of 2026, a report of:

(1)
�
The studies funded and efforts
supported by the mental health emerging therapies special fund in the previous
year;

(2)
�
The department's findings and
recommendations; and

(3)
�
Any proposed legislation.

����
(e)
�
For the purposes of this section:

����
"Compassionate
use" means treating patients suffering from terminal or life-threatening
conditions, including treatment‑resistant mental health conditions under
either the federal Right to Try Act (P.L. 115-176) or the Food and Drug
Administration Expanded Access program (21 United States Code section 360bbb(b)).

����
"Emerging
therapies" means any psychedelic or entactogenic compound or mixture that
is either:

����
(1)
�
Undergoing clinical trials regulated
by the United States Food and Drug Administration for the treatment of a mental
or behavioral health condition;

����
(2)
�
Approved by the United States Food
and Drug Administration for marketing in interstate commerce; or

����
(3)
�
Approved for medical use under
Hawaii law.

����
"United
States Food and Drug Administration breakthrough therapies" means
investigational drugs that have been granted breakthrough therapy designation
by the United States Food and Drug Administration under section 506(a) of the
Food, Drug, and Cosmetic Act (21 United States Code section 356(a)).
"

����
SECTION
2.
�
There is appropriated out of the
general revenues of the State of Hawaii the sum of $
��������
or so much thereof as may be necessary
for fiscal year 2025-2026 and the same sum or so much thereof as may be
necessary for fiscal year 2026-2027 for deposit into the mental health emerging
therapies special fund.

����
SECTION
3.
�
There is appropriated out of the
mental health emerging therapies special fund the sum of $
���������
or so much thereof as may be
necessary for fiscal year 2025-2026 and the same sum or so much thereof as may
be necessary for fiscal year 2026-2027 for supporting clinical research and the
use of emerging therapies for treating mental and behavioral health disorders.

����
The
sums

appropriated shall be expended
by the department of health for the purposes of this Act.

����
SECTION
4.
�
New statutory material is
underscored.

����
SECTION
5.
�
This Act shall take effect on July 1,
2025.

INTRODUCED BY:

_____________________________

Report Title:

DHS;
Mental Health; Emerging Therapies, Breakthrough Therapies; Special Fund;
Reports; Appropriation

Description:

Establishes
and appropriates moneys for a mental health emerging therapies special fund, to
be administered by the Department of Health.
�

Requires annual reports to the Legislature.

The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.